Skip to main content
. 2021 Sep 1;14:4313–4328. doi: 10.2147/JIR.S322430

Figure 1.

Figure 1

Workflow illustration. Peripheral blood samples collected from different sample cohorts were pre-processed. The biomaterials were inactivated prior to proteomic analysis, and complex differentially expressed protein (DEP) data were subjected to multivariate computational analysis for biological interpretation of the different stages of the coronavirus disease process. The datasets were filtered, and potential COVID-19-related biomarker panels were identified. The details of the clinical and demographic characteristics of all the samples are listed in.Table 1